Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36,067 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The immunologic and hematopoietic profiles of mesenchymal stem cells derived from different sections of human umbilical cord.
Xu M, Zhang B, Liu Y, Zhang J, Sheng H, Shi R, Liao L, Liu N, Hu J, Wang J, Ning H, Liu T, Zhang Y, Chen H. Xu M, et al. Among authors: liu y, liu n, liu t. Acta Biochim Biophys Sin (Shanghai). 2014 Dec;46(12):1056-65. doi: 10.1093/abbs/gmu100. Epub 2014 Nov 5. Acta Biochim Biophys Sin (Shanghai). 2014. PMID: 25377438 Free article.
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.
Xu L, Chen H, Chen J, Han M, Huang H, Lai Y, Liu D, Liu Q, Liu T, Jiang M, Ren H, Song Y, Sun Z, Wang J, Wu D, Zhou D, Zou P, Liu K, Huang X. Xu L, et al. Among authors: liu k, liu q, liu d, liu t. J Hematol Oncol. 2018 Mar 2;11(1):33. doi: 10.1186/s13045-018-0564-x. J Hematol Oncol. 2018. PMID: 29495966 Free PMC article. Review.
The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China.
Wang Y, Chen H, Chen J, Han M, Hu J, Jiong Hu, Huang H, Lai Y, Liu D, Liu Q, Liu T, Jiang M, Ren H, Song Y, Sun Z, Wang C, Wang J, Wu D, Xu K, Zhang X, Xu L, Liu K, Huang X. Wang Y, et al. Among authors: liu k, liu q, liu d, liu t. Cancer Lett. 2018 Dec 1;438:63-75. doi: 10.1016/j.canlet.2018.08.030. Epub 2018 Sep 11. Cancer Lett. 2018. PMID: 30217562 Review.
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study.
Xu W, Zhou K, Wang T, Yang S, Liu L, Hu Y, Zhang W, Ding K, Zhou J, Gao S, Xu B, Zhu Z, Liu T, Zhang H, Hu J, Ji C, Wang S, Xia Z, Wang X, Li Y, Song Y, Ma S, Tang X, Zhang B, Li J. Xu W, et al. Among authors: liu l, liu t. Am J Hematol. 2023 Apr;98(4):571-579. doi: 10.1002/ajh.26826. Epub 2023 Jan 22. Am J Hematol. 2023. PMID: 36683422 Free article. Clinical Trial.
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial.
Xu PP, Fu D, Li JY, Hu JD, Wang X, Zhou JF, Yu H, Zhao X, Huang YH, Jiang L, Liu F, Su LP, Chen ZW, Zeng QS, Chen JP, Fang MY, Ma J, Liu T, Song YP, Yu K, Li Y, Qiu LG, Chen XQ, Gu J, Yan JS, Hou M, Huang HY, Wang L, Cheng S, Shen Y, Xiong H, Chen SJ, Zhao WL. Xu PP, et al. Among authors: liu f, liu t. Lancet Haematol. 2019 Jun;6(6):e328-e337. doi: 10.1016/S2352-3026(19)30051-1. Lancet Haematol. 2019. PMID: 31126528 Clinical Trial.
36,067 results
You have reached the last available page of results. Please see the User Guide for more information.